These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Direct analysis of the binding of the abl Src homology 2 domain to the activated epidermal growth factor receptor. Zhu G; Decker SJ; Mayer BJ; Saltiel AR J Biol Chem; 1993 Jan; 268(3):1775-9. PubMed ID: 7678409 [TBL] [Abstract][Full Text] [Related]
5. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase. Muller AJ; Pendergast AM; Parmar K; Havlik MH; Rosenberg N; Witte ON Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3457-61. PubMed ID: 7682703 [TBL] [Abstract][Full Text] [Related]
6. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Mayer BJ; Hirai H; Sakai R Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740 [TBL] [Abstract][Full Text] [Related]
7. Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. Duyster J; Baskaran R; Wang JY Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1555-9. PubMed ID: 7533294 [TBL] [Abstract][Full Text] [Related]
8. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase. Bradshaw JM; Mitaxov V; Waksman G J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of an SH2-kinase construct of c-Abl and effect of the SH2 domain on kinase activity. Lorenz S; Deng P; Hantschel O; Superti-Furga G; Kuriyan J Biochem J; 2015 Jun; 468(2):283-91. PubMed ID: 25779001 [TBL] [Abstract][Full Text] [Related]
10. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. Mayer BJ; Jackson PK; Baltimore D Proc Natl Acad Sci U S A; 1991 Jan; 88(2):627-31. PubMed ID: 1703304 [TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain. Brasher BB; Roumiantsev S; Van Etten RA Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652 [TBL] [Abstract][Full Text] [Related]
13. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576 [TBL] [Abstract][Full Text] [Related]
14. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148 [TBL] [Abstract][Full Text] [Related]
15. Two-state dynamics of the SH3-SH2 tandem of Abl kinase and the allosteric role of the N-cap. Corbi-Verge C; Marinelli F; Zafra-Ruano A; Ruiz-Sanz J; Luque I; Faraldo-Gómez JD Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3372-80. PubMed ID: 23959873 [TBL] [Abstract][Full Text] [Related]
16. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface. Lubman OY; Waksman G J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339 [TBL] [Abstract][Full Text] [Related]
17. Mutational investigation of the specificity determining region of the Src SH2 domain. Bradshaw JM; Mitaxov V; Waksman G J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756 [TBL] [Abstract][Full Text] [Related]
18. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain. Mysliwiec T; Perego R; Kruh GD Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720 [TBL] [Abstract][Full Text] [Related]
19. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded. Buffa P; Manzella L; Consoli ML; Messina A; Vigneri P Proteins; 2007 Apr; 67(1):1-11. PubMed ID: 17211892 [TBL] [Abstract][Full Text] [Related]
20. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor. Yu HH; Zisch AH; Dodelet VC; Pasquale EB Oncogene; 2001 Jul; 20(30):3995-4006. PubMed ID: 11494128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]